Alaska ID ECHO: HCV-HIV-PrEP-STIs
Learn together, care together.
Alaska ID ECHO aims to increase Tribal health care providers’ knowledge about prevention strategies, screening, diagnosing, treatment, and management of HCV, HIV, PrEP and common STIs.
This ECHO (Extension for Community Healthcare Outcomes) is for Tribal and community primary care health providers, nurses, pharmacists, and behavioral health care providers in Alaska to learn best practices and gain competence and confidence in preventing HIV infection with PrEP, preventing HCV and STIs, and caring for Alaska Native/American Indian patients facing HCV-HIV-STI diagnoses.
Do you or your team have a patient case or question? Our ECHO consultant team includes hepatologists, infectious disease specialists, an HIV pharmacy specialist and addiction medicine specialist who are available to provide treatment input.
Contact:
Please contact
us about submitting a case presentation or for any questions.
Register here for updates and to receive the Zoom link.
Held the second Tuesday of each month noon-1 p.m. Alaska Standard Time, via Zoom and hosted by the ANTHC Liver Disease and Hepatitis Program and ANTHC Early Intervention Services/HIV Clinical Services and in partnership with IndianCountryECHO.org.
Accredited continuing education available.
AK ID ECHO: HCV-HIV-PrEP-STIs Schedule:
May 14 | Hepatitis A in Alaska – Has it disappeared or will it come back? |
June 11> | Hepatitis C Update |
July 9 | Common concerns and misconceptions around MOUD |
August 13 | TBA |
September 10 | TBA |
October 80 | TBA |
November 12 | TBA |
December 10 | TBA |
PrEP Series – Enduring CE’s available until April 30, 2025
Syphilis Training – Enduring CE’s available until March 31, 2026
Past Session Recordings (No enduring CE’s):
If you would like to request presentation slides please email, akidecho@anthc.org.
- HIV Update, didactic recording
- Antimicrobial stewardship in primary care, didactic recording
- Rapid Testing and Resources, didactic recording
- Syphilis 101, didactic recording, slides, documents
- Congenital Syphilis, didactic recording
- Naloxone 101, didactic recording
- DoxyPEP, didactic recording
- Hepatitis B, didactic recording
- Mycoplasma genitalium STI, didactic recording
- Overview of HIV Injectable Medications, didactic recording
- People Living with HIV and Breastfeeding, didactic recording
- TB in Alaska Update, didactic recording
- HCV Treatment in Non-Traditional Settings, didactic recording
- Hepatitis EPI in AK, didactic recording
- HIV Update, didactic recording
- STI EPI Update, didactic recording
- Drug Interaction Considerations with Gender Affirming Hormone Therapy, didactic recording
- Hepatitis B Screening and Lab Interpretation, didactic recording
- HCV Reinfection, didactic recording
- Public Health Reporting – procedures, processes and follow-up, didactic recording
- Common drug interactions part 2: now adding COVID Tx meds into the mix, didactic recording
- Common drug interactions for commonly prescribed medications for HCV, HIV, STIs – part 1, didactic recording
- HIV Treatment and Prevention – new injectable drugs, didactic recording
- Simplified HCV Treatment, didactic recording
- Congenital Syphilis, didactic recording
- TB update in Alaska and who should be tested, didactic recording
- HCV Epidemiology, Alaska Elimination Plan, didactic recording
- Stigma with patient perspective, didactic recording
- STI prevention programs, initiatives, harm reduction resources, didactic recording
- How to take a sexual history, didactic recording
- Post-Exposure Prophylaxis (PEP), didactic recording
- STI Epidemiology, Screening, Treating: Chlamydia/Gonorrhea & EPT, didactic recording
- STI Epidemiology, Screening, Treating: Syphilis, didactic recording, slides, documents
- STI Epidemiology, Screening, Treating: HIV, didactic recording
- 2020 AASLD Update: What’s new with HCV Treatment, didactic recording
- PrEP 101 – Pre Exposure Prophylaxis for HIV, didactic recording
This project is funded by the Minority HIV/AIDS Fund through the Indian Health Service.